Pharma, Biotech and Generics Industry News | The Pharmaletter
WEBSep 17, 2024 · Italian biotech Genespire—which is developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases—has announced the closing of a 46.6 million euros ($52 million) Series B financing. 25 September 2024. Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of ...
Pharmaceutical Industry News | The Pharmaletter
WEBSep 5, 2024 · Centivo secures $75 million to expand affordable healthcare. Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024. More Pharmaceutical News >. 24 September 2024. 22 September 2024.
USA Clears Ivermectin For Human Use - The Pharma Letter
WEBDec 2, 1996 · USA Clears Ivermectin For Human Use. 2 December 1996. In the USA, the Food and Drug Administration has approved Merck & Co's Stromectil (ivermectin) for its first non-veterinary use, the chemotherapy of two parasitic infections, strongyloidiasis and onchocerciasis, in humans. Ivermectin has been used …
Special Reports - The Pharma Letter
WEBJun 17, 2020 · Our latest Special Report is a review of key factors impeding progress of US biosimilar adoption written by Helen Ji, an associate at Schiff Hardin LLP, Rekha Hanu, executive director and chief IP counsel at Akorn Pharmaceuticals and Christine Simmon, SVP for policy and strategic alliances at the Association for Accessible Medicines. 4 …
EMA drug regulation and approval news | The Pharmaletter
WEBSep 21, 2024 · AstraZeneca’s Marketing Authorization Application (MAA) for sipavibart has been accepted under an accelerated assessment procedure by the European Medicines Agency (EMA), for the pre-exposure prophylaxis (prevention) of COVID-19 in immunocompromised patients. 1 July 2024.
Global drugmakers continue to control over 60% of drug public ...
WEBSep 20, 2023 · Global drugmakers continue to control over 60% of drug public procurements in Russia. The share of foreign pharmaceutical companies in the segment of public procurement in Russia reached 63%, the highest figure in the last six years, according to latest market statistics in Russia and local media, reports the Pharma Letter’s local correspondent.
Annual revenue of top 10 big pharma companies
WEBMar 3, 2020 · Below is a graph of this year’s top 10 pharma companies, ranked by pharmaceutical revenue, along with a table with more on their performance compared to last year. Pfizer (NYSE: PFE) maintained pole position with full year revenues of $51.75 billion, but sales declined by 4% year-on-year as key …
About The Pharma Letter | The Pharmaletter
WEB4 days ago · The Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the company draws from a network of foreign correspondents, with healthcare journalists around the world providing insight on local markets.
Ribon Therapeutics inks pre-clinical CD38 program deal with …
WEB30 November 2022. Cambridge, USA-based biotech Ribon Therapeutics has entered into an agreement on the acquisition of its CD38 program with Germany’s family-owned pharma major Boehringer Ingelheim. This includes a small molecule inhibitor designed to modulate intra- and extracellular CD38 activity, potentially restoring immune function in ...
MolMed | Biotechnology - The Pharmaletter
WEBItalian biotech firm MolMed SpA (Milan: MLM) is a medical biotechnology company focused on research, development and clinical validation of innovative therapies to treat cancer. It has two innovative anticancer therapeutics in Phase III clinical trials with first regulatory submissions planned in 2013. NGR-hTNF is a first-in-class vascular ...